Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Alendronate Suppress Aortic and Coronary Artery Calcification and Improve Bone Mineral Density in Chronic Peritoneal Dialysis Patients?

NCT00261625 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT00261625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00261625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Alendronate Suppress Aortic and Coronary Artery Calcification and Improve Bone Mineral Density in Chronic Peritoneal Dialysis Patients?
Lead sponsor
National Taiwan University Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2005
Completion date
October 31, 2007
Enrollment
50 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

end-stage renal disease, osteoporosis